SIGA Technologies Inc. Common Stock
(NASDAQ:SIGA)
Description
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an orally administered antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was founded in 1995 and is headquartered in New York, New York.
SIGA Overview
None
Sector |
Health Care |
Industry |
Major Pharmaceuticals |
Previous Close |
$4.9600 |
Previous Close Volume |
341030 |
Latest News
- ARCA biopharma Announces 1-for-12 Reverse Stock Split in Connection with the Proposed Merger with Oruka Therapeutics 23 Aug 2024 17:33:29
- ARCA biopharma Declares Special Dividend in Connection with the Proposed Mergerwith Oruka Therapeutics 22 Aug 2024 18:03:07
- ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update 22 Aug 2024 15:03:15
- ARCA biopharma Announces Second Quarter 2024 Financial Results and Provides Corporate Update 22 Aug 2024 14:32:58